This review discusses glutamatergic modulators in treating major depression, focusing on NMDA-targeted therapies like ketamine and esketamine.

This study investigates factors predicting the transition from major depression to bipolar disorder using data from a Swedish national longitudinal cohort. The findings highlight early age of onset as a significant risk factor for conversion, while the role of sex remains inconclusive. The study emphasizes the importance of early identification...